Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/RZcueJVqjC4/257117.php
Tuesday, 5 March 2013
Averting Graft-Versus-Host Disease In Patients With Leukemia, Lymphoma, Multiple Myeloma
Bone marrow transplant is a key treatment for patients with leukemia, lymphoma, multiple myeloma and other blood disorders. University of Michigan researchers have discovered that inhibiting a signaling pathway in some of the transplanted cells could prevent the most serious potential complications of the procedure, a conflict between the transplanted cells and the recipient's own tissue called graft-versus-host disease. In a paper published online in the Journal of Clinical Investigation, Dr...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment